# Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia

> **NCT01714570** · NA · COMPLETED · sponsor: **Chinese PLA General Hospital** · enrollment: 123 (actual)

## Conditions studied

- Febrile
- Neutropenia
- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Piperacillin-tazobactam combination product
- **DRUG:** Imipenem

## Key facts

- **NCT ID:** NCT01714570
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2014-03
- **Final completion:** 2014-04
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2014-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01714570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01714570, "Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01714570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*